Globally, synovial sarcoma remains a rare but aggressive malignancy with a 5-year survival rate of 70% to 80% and a 10-year ...

Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific ...

Detailed price information for GE Healthcare Technologies Inc (GEHC-Q) from The Globe and Mail including charting and trades.

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research ...

In the months and years after East Palestine’s train derailment, researchers from five universities started studies on the environmental and health effects. Those researchers presented their ...

Contrary to fears of AI replacing jobs, a Harvard study reveals ChatGPT acts as a practical assistant for students and ...

The study also emphasized that these results align with the Japan Agency for Medical Research and Development (AMED) initiatives to promote PPIE as part of national health policy. Their presentation ...

Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease ...

Alnylam Pharmaceuticals, Inc. is rated Hold due to high expectations, competitive threats, and revenue expansion. Learn more ...

Inflammatory cardiomyopathy remains a challenging condition characterized by inflammation of the heart muscle, which often results from a diverse range of ...